Abstract
The mu opioid receptor (MOR) plays a critical role in modulating social behavior in humans and animals. Accordingly, MOR null mice display severe alterations in their social repertoire as well as multiple other behavioral deficits, recapitulating core and secondary symptoms of autism spectrum disorder (ASD). Such behavioral profile suggests that MOR dysfunction, and beyond this, altered reward processes may contribute to ASD etiopathology. Interestingly, the only treatments that proved efficacy in relieving core symptoms of ASD, early behavioral intervention programs, rely principally on positive reinforcement to ameliorate behavior. The neurobiological underpinnings of their beneficial effects, however, remain poorly understood. Here we back-translated applied behavior analysis (ABA)-based behavioral interventions to mice lacking the MOR (Oprm1−/−), as a model of autism with blunted reward processing. By associating a positive reinforcement, palatable food reward, to daily encounter with a wild-type congener, we were able to rescue durably social interaction and preference in Oprm1−/− mice. Along with behavioral improvements, the expression of marker genes of neuronal activity and plasticity as well as genes of the oxytocin/vasopressin system were remarkably normalized in the reward/social circuitry. Our study provides further evidence for a critical involvement of reward processes in driving social behavior and opens new perspectives regarding therapeutic intervention in ASD.
Similar content being viewed by others
Introduction
Within the opioid system, the mu opioid receptor (MOR) plays a key role in mediating the rewarding properties of natural and artificial stimuli such as food or drugs of abuse1,2. Stemming from the pioneer work of Panksepp and colleagues3, evidence from imaging, experimental psychology, and behavioral pharmacology have uncovered how MOR activation also underpins social reward and motivation in humans and animals and, consequently, modulates varieties of social behaviors (sexual and affiliative behaviors, bonding, social play, social exploration)4,5,6,7,8. Consistent with this, genetic knockout of MOR (Oprm1−/−) in mice produces severe alterations of their social repertoire, from early life to adult age9,10,11,12, further demonstrating that MOR is essential for establishing appropriate social behavior. Oprm1−/− animals were recently proposed to model autism spectrum disorder (ASD)9,13, a heterogeneous group of neurodevelopmental diseases whose diagnosis lies on the detection of two types of core symptoms: deficient social reciprocity and communication together with restricted, repetitive patterns of behavior14,15. Remarkably, not only MOR null mice recapitulate all these core symptoms but they also display multiple behavioral and physiological abnormalities frequently associated to ASD7,9,14, proving unique face validity for this model16. Moreover, these animals show several neurobiological landmarks of the disease, such as altered striatal function, decreased activation of the reward circuit in response to social stimuli or reduced oxytocin in the nucleus accumbens9,11,17,18,19,20,21 that, together with the identification of ASD patients bearing mutations in the OPRM1 gene7, demonstrate construct validity for this model. Given the key role of MOR in modulating reward, these data suggest, beyond a potential contribution of MOR dysfunction in ASD, that altered reward processes may represent a key mechanism underlying ASD etiopathogeny. Interestingly, a growing body of literature points to reward deficits in patients with ASD7,18, in agreement with the social motivation theory of autism proposing that disrupted social interest in these patients would result primarily from early deficits in their motivation for attending, enjoying and prolonging social interactions22,23.
If compromised reward processes were to account for behavioral deficits in ASD, a straightforward consequence would be that facilitating these processes in patients should represent an efficient tool to relieve autistic symptoms. To date, available pharmacological treatments for ASD mostly target associated symptoms24,25 and evidence-based behavioral interventions remain the only treatments that proved to ameliorate core symptoms26,27,28,29. Strikingly, the most widely used and longest standing intervention models, Early Intensive Behavioral Intervention (EIBI) programs, based on applied behavioral analysis (ABA), use various behavioral techniques relying on positive reinforcement as levers to shape behavior30,31,32,33,34. Concretely, EIBI programs break desirable behaviors (direct eye gaze or speech for example) down into steps and reward success at each step; conversely, these therapies may resort to punishment to discourage behaviors considered as inappropriate (tantrums for example). Directly derived from ABA-based EIBI, novel interventions have recently emerged (such as the Early Start Denver Model, enhanced Milieu teaching, Pivotal Response Treatment, parent-implemented programs), often play-based, in which the intervention is more child-directed and occurs in “naturalistic” environments, to facilitate generalization to the child’s everyday life35,36,37,38,39,40. A common feature of all these interventions remains the use of direct positive reinforcers to promote behavioral improvements, whereas punishment is mostly discarded29,36,41. Reinforcers are often edible or tangible items, such as palatable food, preferred by patients with ASD over more social reinforcement, like praise42,43. Thus, evidence-based behavioral intervention involves stimulating the reward system to increase the occurrence of appropriate behavior, particularly within the social repertoire, which is in accordance with a reward hypothesis in ASD.
Although they have demonstrated their efficacy, behavioral intervention programs show some limitations. Indeed, these programs are highly demanding to children and their families: they need to be intensive (20–40 h per week) and ought to start at the youngest possible age;44,45,46 however, their outcome remains uncertain. Therapists are seeking experimental evidence and biomarkers to identify key elements predictive of positive results for each patient. In this context, transposing the basic principles of behavioral intervention to mouse models offers a unique opportunity to decipher their neurobiological underpinnings. Here, we back-translated such intervention to Oprm1−/− mice, as a model of ASD with demonstrated reward deficiency, to assess whether associating positive reinforcement to social experience in these animals could rescue their impaired social abilities (and, eventually, other behavioral deficits), which would argue for a crucial contribution of reward processes in the beneficial effects of behavioral intervention. Moreover, we investigated gene expression in key brain regions for reward processing and social behavior in these animals to better delineate the molecular substrates of these effects.
Materials and methods
Animals, housing conditions, and breeding procedures
Male and female Oprm1+/+ and Oprm1−/− mice47 were bred in-house on an identical hybrid background: 50% 129SVPas - 50% C57BL/6 J. Oprm1+/+ and Oprm1−/− pups were bred from homozygous parents, as we previously showed that parental care has no influence on behavioral phenotype in these animals (cross-fostering experiments, see ref. 9). Homozygous parents, however, were bred from heterozygous animals, to prevent genetic derivation. This breeding scheme may have potentiated behavioral deficits in mutant animals by maintaining them together during early postnatal development. Except otherwise stated, animals were group-housed and maintained on a 12 h light/dark cycle (lights on at 7:00 AM) at controlled temperature (21 ± 1 °C); food and water were available ad libitum. Experiments were analyzed blind to genotypes and experimental condition. All experimental procedures were conducted in accordance with the European Communities Council Directive 2010/63/EU and approved by the Comité d’Ethique pour l’Expérimentation Animale de l’ICS et de l’IGBMC (Com’Eth, 2012-033) and Comité d’Ethique en Expérimentation animale Val de Loire (C2EA-19).
Behavioral experiments
Behavioral training protocol
Equivalent numbers of naive male and female animals were used in each group. Female mice were not synchronized for estrous cycle. Experiments started when mice were 6-week old, in an attempt to mimic early intervention conditions. Caregivers in EIBI programs initially define several target behaviors to work on; here we focused on social interaction. Animals were randomly distributed across four experimental conditions before behavioral assays had started: object interaction-reinforced (OI-R), social interaction-nonreinforced (SI-NR), social interaction-reinforced (SI-R), and No Training control (NoT) (see details below and in Fig. 1a). We performed behavioral testing in three steps (time line in Fig. 1b).
Pre-training tests
To match clinical conditions48, we first evaluated which reinforcer was preferred in our animals between two highly palatable diets: condensed milk or peanut butter. This allowed us to determine the type of palatable food reinforcer to use in further experiments for each animal. Preference was measured in a Y-maze, and exploration pattern during habituation was used to assess perseverative behavior. We evaluated social abilities using the direct social interaction test (postnatal—PN–week 6, see supplemental information for detailed protocols).
Behavioral training
Behavioral training started on PN week 7 and lasted 3 weeks. In the SI-R condition (experimental group), mutant and wild-type mice interacted 5 days a week with a wild-type unfamiliar conspecific, different every day, for 5 min during the first 2 weeks, for 8 min during the 3rd week. The interactor was then removed from the arena, whereas the experimental animal remained another 5 (or 8 min) and received a ∼ 3 g unit of its favorite food reward. The amount of food was weighted before and after the test to measure consumption. In a first control group, the SI-NR group, training was performed under the same conditions except that no food reward was available in the arenas following social interaction. In SI-NR and SI-R groups, the time spent in nose contacts and their duration were measured during the course of training to assess the evolution of social behavior (days 2, 4, 8, 12, and 14). During the two last training sessions, some male mice (Oprm1+/+ and Oprm1−/−) from the SI-R group developed aggressive behavior, maybe a territorial response owing to repetitive food presentation in the arena. In a second control group, the OI-R group, food reward was offered to the animals after exposure to an unfamiliar object (different every day) instead of a mouse. The amount of food consumed was measured. Finally, in a no training control group (NoT), the animals were tested on PN weeks 6, 10, and 11 under the same conditions as in the other groups, but were not manipulated during PN weeks 7–9.
Post-training tests
Beginning on PN week 10, we performed multiple assays to assess the consequences of behavioral training. Social abilities were explored using the direct social interaction (between unfamiliar animals of the same genotype and experimental group) and three-chamber tests49. Stereotyped/perseverative behavior was assessed by scoring motor stereotypies50, monitoring alternation in a Y-maze51, and assessing anxiety-induced marble burying52. Anxiety was evaluated in the novelty suppressed feeding test53 (testing order in Figure S1). Detailed behavioral protocols are described in Supplemental information.
In cohorts dedicated to qRT-PCR analysis (half of the OI-R, SI-NR, and SI-R cohorts), animals were submitted to three additional days of behavioral training (week 12), and killed 45 min after the beginning of an additional social interaction session without food presentation (Fig. 1b). To assess the maintenance of training effects over the time, we submitted the other half of the SI-NR and SI-R cohorts to a direct social interaction test on PN weeks 17 and 24 (detailed protocol in Supplemental information).
Real-time quantitative PCR analysis
Brains were removed and placed into a brain matrix (ASI Instruments, Warren, MI, USA). Caudate putamen (CPu), nucleus accumbens (NAc), central amygdala (CeA), and ventral tegmental area/substancia nigra pars compacta (VTA/SNc) were punched out, whereas prefrontal cortex (PFC) and medial amygdala (MeA) were dissected from 1 mm-thick slices (see Figure S2). Tissues were immediately frozen on dry ice and kept at − 80 °C until use. For each structure of interest, genotype, and condition, samples were prepared from three male and three female mice and processed individually (n = 6). RNA was extracted and purified using the MIRNeasy mini-kit (Qiagen, Courtaboeuf, France). cDNA was synthetized using the first-strand Superscript II kit (Invitrogen®, Life Technologies, Saint Thomas, France). qRT-PCR was performed as previously described9. Primer sequences are displayed in Table S1.
Statistical analyses
Statistical analyses were performed using Statistica 9.0 software (StatSoft, Maisons-Alfort, France). All data were initially checked for normality of distribution using Kolmogorov–Smirnov’s test of normality. For all comparisons, values of p < 0.05 were considered as significant. Statistical significance in behavioral experiments was assessed using three- to four-way analysis of variance (genotype, gender, condition, and training effects) followed by Newman–Keuls post hoc test. Variance was similar between compared groups. We defined sample size (GPower 3.1) to ensure sufficient statistical power using ANOVA to detect significant effect of our parameters (effect size f = 1.80, α = 0.05, σ = 5, n = 8, power = 0.96). Significance of qRT-PCR results was assessed after transformation using a one-sample t test, as previously described9. A standard principal component analysis (PCA) was performed on behavioral and qRT-PCR data9. Loadings for each extracted principal component (PC) are quoted in Table S2. We considered the two first extracted PCs (PC1 and PC2) for schematic representation.
Results
Before behavioral training, mice lacking the MOR show perseverative behavior in the Y-maze and severe deficit in social interaction
We assessed social behavior using the direct social interaction test in mice belonging to the four experimental groups (NoT, OI-R, SI-NR, SI-R) before behavioral intervention. The sex of animals had no significant influence on these parameters. All Oprm1−/− mice, whatever the group they belonged to, displayed deficient social interaction, as evidenced by decreased time spent in nose contact (NC–genotype effect: F1,125 = 379.2, p < 0.0001), lower number of NC (F1,125 = 99.2, p < 0.0001), decreased mean duration of NC (F1,125 = 227.0, p < 0.0001), and reduced number of following episodes (F1,125 = 204.3, p < 0.0001). Moreover, mutant animals groomed more than wild-type controls (F1,125 = 21.3, p < 0.01), especially following a social contact (F1,125 = 252.3, p < 0.0001), a sign of social discomfort9,54 (Fig. 2a, statistics in Table S3). We evaluated perseverative behavior before behavioral training by recording the animal’s pattern of exploration in the Y-maze (Fig. 2b). Oprm1−/− animals from all groups displayed lower rates of spontaneous alternation than Oprm1+/+ animals (genotype: F1,125 = 26.2, p < 0.0001), consistent with an increased number of perseverative same arm returns in mutant mice (F1,125 = 23.3, p < 0.0001). Finally, we measured preference for condensed milk over peanut butter when these reinforcers were made available in the Y-maze. In this test, similar numbers of Oprm1+/+ and Oprm1−/− animals preferred one over the other reinforcer (percentage of animals preferring condensed milk: Oprm1+/+ 50.69%; Oprm1−/− 50.13%, Fig. 2c).
Palatable food intake and social interaction increased during the course of behavioral training in Oprm1 +/+ and Oprm1 −/− mice
Over the course of training, Oprm1+/+ and Oprm1−/− animals increased their intake of palatable food, with mutant mice consuming less (genotype effect: F1,64 = 10.3, p < 0.01; training effect: F14,386 = 6.2, p < 0.0001) (Figure S3a), especially females (Figure S3b). To assess the evolution of social behavior during training, we monitored (SI-NR and SI-R groups) the time spent in and number of NC, and calculated the mean duration of NC. The three parameters increased over time in both groups (training: time in NC–F4,70 = 12.1, p < 0.0001; number of NC–F4,70 = 5.4, p < 0.001; duration of NC: F4,70 = 15.4, p < 0.0001) with NC in the SI-R group being more numerous than in the SI-NR group (condition: F1,70 = 6.1, p < 0.05) than in the SI-R group (Figure S4a, statistics in Table S4). These two parameters, however, did not differ between genotypes, maybe because wild-type interactors initiated most of the social contacts during these sessions. The mean duration of NC, however, was shorter in Oprm1−/− animals than in Oprm1+/+ controls, and increased more significantly under the SI-R than the SI-NR condition (genotype: F1,70 = 13.0, p < 0.001; condition: F1,70 = 10.6, p < 0.01; training × genotype: F4,70 = 2.6, p < 0.05). Gender had little influence on these parameters (Figure S4b). Thus, daily exposure to an unfamiliar congener increased the number and duration of NC in mice, especially when this exposure was reinforced with food.
Behavioral intervention (SI-R) durably relieved social interaction deficit in Oprm1 −/− mice
We assessed social behavior in mice submitted to the four different conditions of behavioral training using two assays: the direct social interaction test and the three-chamber social preference test. In the former, Oprm1−/− mice from the NoT and OI-R groups still displayed a marked deficit in social interaction as compared to their wild-type controls, although the number of grooming episodes, including these occurring after social contact, was reduced in OI-R versus NoT mutant animals. Knockout mice from the SI-NR group showed restored number of NC as compared with their Oprm1+/+ controls, increased time spent in NC and mean duration of NC and decreased total number of grooming episodes when compared with knockout animals of the NoT group. However, the number of following episodes and grooming episodes after social contact were unchanged as compared with this control. Finally, all interaction parameters were normalized to wild-type levels in male and female Oprm1−/− mice trained under the SI-R condition (genotype × treatment: time in NC–F3,125 = 28.0, p < 0.0001; number of NC–F3,125 = 18.1, p < 0.0001; duration of NC–F3,125 = 24.6, p < 0.0001; following—F3,125 = 18.3, p < 0.0001; number of grooming episodes—F3,125 = 13.0, p < 0.01; grooming after social contact—F3,125 = 40.7, p < 0.0001; Fig. 3a, more parameters and sex effects in Figure S5, statistics in Table S5). We further tested social interaction in half of the SI-NR and SI-R cohorts 7 and 14 weeks after cessation of training and observed a persistence of the beneficial effects of behavioral training in mutants from the SI-R but not the SI-NR group, as illustrated by maintained normalization of the time in NC. Interestingly, 14 weeks after cessation of training time in NC was also higher in Oprm1+/+ mice from the SI-R group compared with SI-NR (training × genotype × condition: F3,84 = 13.6, p < 0.0001) (Fig. 3b, more parameters and sex effects in Figure S6, statistics in Table S6).
We further assessed social behavior across experimental groups using the three-chamber test after behavioral training (Fig. 3c and S7). In this test, male and female Oprm1−/− mice from the NoT, OI-R, and SI-NR groups displayed a significant deficit in social preference, as shown by absent preference for time spent in close contact with the mouse over the toy (stimulus × genotype × condition: F3,123 = 9.7, p < 0.0001), longer duration of close contacts with the toy versus the mouse (stimulus × genotype × condition: F3,123 = 41.4, p < 0.0001) and, consequently, diminished preference ratios (genotype × condition: F3,123 = 15.5, p < 0.0001) when compared with respective Oprm1+/+ controls. In contrast, mutant animals trained under the SI-R condition preferred to spend more time in close contact with the mouse over the toy, displayed longer close contacts with the mouse and accordingly showed a fully restored preference ratio as compared with Oprm1+/+ animals from the same group (statistics in Table S5). Thus, beneficial effects of behavioral intervention in Oprm1−/− mice trained under the SI-R condition generalized to social preference measured in the three-chamber test.
Beneficial effects of behavioral intervention in mutant mice were limited to the social repertoire
We assessed whether the effects of behavioral training on social behavior would extend to other, non-social, behavioral deficits in Oprm1−/− mice. We measured spontaneous motor stereotypies in all groups after training. Mutant mice displayed more frequent grooming (genotype: F1,125 = 8.1, p < 0.01), burying (F1,125 = 5.7, p > 0.05), circling (F1,125 = 113.3, p < 0.0001), and shakes (F1,125 = 30.5, p < 0.0001) than wild-type animals independently from the experimental condition, except for grooming that was lower in the SI-NR group (condition: F3,125 = 2.9, p < 0.05). Also, burying episodes were shorter in Oprm1−/− compared with Oprm1+/+ animals through all conditions (genotype: F1,125 = 12.0, p < 0.001) (Fig. 4a). In the marble burying test, knockout mice buried more marbles than wild-type animals, with no significant effect of the experimental condition (genotype: F1,125 = 9.0, p < 0.05) (Fig. 4b). Similarly, in the Y-maze test, behavioral training failed to reduce the number of perseverative same arm entries (genotype: F1,125 = 104.1, p < 0.0001) and restore spontaneous alternation rates (F1,125 = 50.1, p < 0.0001) in mutant mice (Fig. 4c). Finally, we assessed anxiety levels following behavioral training using the novelty suppressed feeding test. In this test, Oprm1−/− mice took longer to eat on the food pellets, with mice from the OI-R, SI-NR, and SI-R condition eating faster than NoT animals. Under the OI-R condition, the latency to feed of Oprm1−/− mice was normalized to wild-type levels (genotype × condition: F3,124 = 24.3, p < 0.0001) (Fig. 4d). This latency was also returned to wild-type levels in male but not female mutant animals trained under the SI-NR and SI-R conditions (gender: F1,124 = 6.8, p < 0.01; gender × genotype × condition: F3,124 = 2.7, p < 0.05) (Figure S5). As regards food intake, Oprm1−/− mice ate less than Oprm1+/+ animals when back in home cage and so did control mice (NoT) compared with other conditions. Mutant mice ate as much as wild-type animals under the OI-R and SI-NR conditions (genotype × condition: F3,124 = 9.0, p < 0.0001; statistics in Table S5). Thus behavioral training reduced anxiety levels in male and female Oprm1−/− mice in the OI-R group. Altogether, these data indicate that such training had limited impact on off-target, non-social, behaviors.
Behavioral intervention normalized gene expression in the reward circuit of Oprm1 −/− mice
To identify molecular correlates of the behavioral improvements detected after training, we assessed in OI-R, SI-NR, and SI-R mice the expression of 12 genes across six brain regions known to play a key role in reward and social behavior: PFC, CPu, NAc, CeA, MeA, and VTA/SNc. We focused on immediate early genes and markers of plasticity (C-fos, Arc/Arg3.1, Bdnf), genes of the oxytocin/vasopressin system (Oxt, Avp, Oxtr, Avpr1a, Avpr1b) because of their key role in social behavior and evidences of altered function in Oprm1−/− mice9,11, autism gene candidates (Nlgn1, Foxp1, Crh) whose expression was dysregulated in this model9 and finally Grm4, encoding mGluR4 receptors whose activation relieves autistic symptoms9. Fold changes were calculated using expression in Oprm1+/+ mice from the OI-R group as a reference; they are presented in Table S7. Among tested genes, C-fos and Oxt particularly retained our attention (Fig. 5a). We detected a decrease in C-fos expression, a marker gene for neuronal activation, in most regions of the social/reward circuit (NAc, CPu, MeA, and VTA/SNc) of Oprm1−/− mice trained under the OI-R condition, except for the PFC and CeA where this expression was increased. Repeated interaction with a conspecific under the SI-NR condition restored C-fos transcription levels totally in the NAc and MeA and partially in the CPu and CeA, but left these levels unchanged in the PFC and VTA/SNc. SI-R training normalized C-fos mRNA levels in all brain regions but the PFC of mutant mice. As regards Oxt expression, we detected reduced levels of transcripts in the NAc, CeA, and MeA of Oprm1−/− mice from the OI-R group. Mutant mice trained under the SI-NR condition exhibited restored levels of Oxt mRNA in the NAc (even increased), partial increase in the CeA and no change in the MeA; the same animals trained under the SI-R condition exhibited normalized levels of Oxt mRNA in all these regions. Thus behavioral intervention rescued deregulated expression of C-fos and Oxt in Oprm1−/− animals, whatever their direction (up- or downregulation). Training under the SI-NR paradigm ameliorated, but only partially, this expression.
We performed a cluster analysis of all qRT-PCR data to visualize patterns of gene expression depending on genotype and experimental condition (Fig. 5b). Hierarchical clustering organized gene expression data in four main clusters. Cluster (A) grouped a majority of genes with upregulated expression in Oprm1−/− mice trained under the SI-NR and OI-R conditions compared with wild-type (SI-NR or SI-R) or mutant SI-R trained animals. Remarkable genes in this cluster were Arc, markedly upregulated in all regions studied for OI-R and SI-NR trained Oprm1−/− mice, Oxtr (coding oxytocin receptors), upregulated in the amygdala of mice from the OI-R and SI-NR groups and Crh, upregulated in the PFC, CPu, and VTA/SNc of mutant animals. Conversely, cluster (C) brought together genes with downregulated expression in OI-R and SI-NR trained mutant mice. Most of these downregulations were detected in the striatum and amygdala (such as C-fos, Oxt, Crh, Bdnf, Grm4, Avpr1a, or Avpr1b). Cluster (B) gathered genes whose expression was not significantly regulated in these regions. Gene expression in cluster (D) was either oppositely regulated between mutant mice trained under the SI-NR and OI-R conditions (C-fos and Oxt in the NAc), not regulated in these groups while increased in other groups (Avp in the NAc, Bdnf in the NAc and CPu) or not regulated. Globally, this analysis unraveled that gene expression pattern in knockout animals trained under the SI-R condition was more similar to that of wild-type animals (SI-NR or SI-R groups) than that of Oprm1−/− mice trained under the SI-NR or OI-R conditions.
Finally, we performed a PCA including social interaction parameters and gene expression data in different regions to assess correlations between these different outputs (Fig. 5c and S8, Tables S2 and S7). We selected three behavioral parameters and 14 qRT-PCR results that together accounted for 81.5% of the variance in this sample (variables’ space, Fig. 5c, top). We found that the time spent in NC and number of following episodes, two measures of prosocial behavior, clustered together and with C-fos expression in the CPu, Oxt expression in the MeA and CeA, Crh mRNA levels in the NAc and Grm4 levels in the CPu. This first cluster was opposed along the first principal component (PC1) to a second centered on the number of grooming episodes occurring immediately after social contact, an index of social avoidance, and gathering expression of Arc in the VTA, CeA, and MeA, Oxtr in the NAc, C-fos in the CeA and Avpr1a in the CeA. Oxt and C-fos expression in the NAc and C-fos levels in the MeA correlated mostly with PC2. Projection in the subjects’ space (Fig. 5c, bottom) dissociated Oprm1−/− individuals of the OI-R and SI-NR groups from Oprm1+/+ mice, with PC2 axis segregating SI-NR from OI-R populations. Remarkably, and consistent with the results of clustering analysis, data from individual Oprm1−/− mice from the SI-R group clustered with those of Oprm1+/+ animals (OI-R, SI-NR, and SI-R condition), showing that, when focusing on this particular set of behavioral and gene expression data, SI-R training (behavioral intervention) normalized Oprm1−/− features.
Discussion
To our knowledge, this is the first report of a successful back-translation of ABA-based EIBI to a murine model of autism. We used mice lacking MOR, which display blunted reward processing1,9,13, a predictor of positive outcome for behavioral intervention in children with ASD55,56, and demonstrated that associating a positive reinforcement to daily encounters with an unfamiliar wild-type congener is sufficient to durably restore direct social interaction, social preference in the three-chamber test and gene expression in the reward/social circuit of these animals, similarly in males and females.
Transposing complex intervention programs such as ABA-based EIBI to a rodent model is a true challenge, and our experimental paradigm shows some methodological limitations. First, EIBI utilize various elaborated paradigms to modify target behaviors in patients with autism30,31,32,33,34, whereas here we used appetitive conditioning solely. However, most of the techniques used in behavioral interventions involve positive reinforcement and thus stimulate the reward system, as we did in the present experiments. As a positive reinforcer, we used food reward, as commonly done in the first stages of EIBI43. Of note, mutant animals, especially females, consumed less-palatable food than Oprm1+/+ mice during the course of training, suggesting reduced motivation for food, as previously described57. These results are in agreement with a key role of MOR in mediating the hedonic “liking” for food58,59. Oprm1−/− mice, however, can learn an operant task to obtain food57,60. In our study, they modified their behavior when exposed to palatable food, further showing that they can use food reward as a reinforcer. Second, EIBI therapists usually reinforce each occurrence of the target behavior immediately (fixed ratio 1) and depending on its quality (differential reinforcement)61,62. Here we instead used a trace conditioning procedure, palatable food being presented with a delay after social encounter, and provided the same amount of food whatever the quality of previous social interaction. Although this paradigm likely made the association between food reward and social experience more difficult to acquire, improved social interaction in Oprm1−/− animals from the SI-R group after training demonstrates that these animals indeed made such association. Importantly, food reward was not able to rescue social interaction when not associated to social experience (OI-R condition), showing that behavioral improvements under the SI-R condition were not due to reward exposure only. Moreover, experiencing social encounter with a wild-type stranger every day without receiving a reward (SI-NR) partially restored social interaction in mutants, in line with clinical reports showing lower symptom severity in patients with ASD interacting with typical peers, notably at school63. These improvements, though, rapidly faded when daily encounters ceased. In contrast, social enrichment produced partial but persistent beneficial effects on social abilities in Oprm1−/− mice when provided from neonatal age64. Earlier training under the SI-NR condition may thus be required to obtain stable social improvements in these animals. Despite the above limitations, our behavioral intervention (SI-R) paradigm successfully allowed us to modify social behavior in Oprm1−/− mice by using positive reinforcement, in agreement with our primary hypothesis.
Remarkably, our transposition of behavioral intervention successfully reproduced several key features of EIBI in MOR null mice. As shown in the clinics29,45, the effects of intervention were long lasting: they were still detectable 14 weeks after complete cessation of intervention. Such long-lasting beneficial effects of SI-NR training were observed independently from the sex of the animals. Clinical studies reporting positive effects of EIBI include both male and female patients; due to limited numbers of girls, however, these studies do not comment on sex effects29,45,65. Interestingly, behavioral intervention (SI-R condition) also showed beneficial effects in Oprm1+/+ mice, by preserving high levels of social interaction in aging (24 weeks) animals. This result further demonstrates the key role played by reward in sustaining social behavior7,66. Furthermore, Oprm1−/− mice of the SI-R group showed only modest improvements in off-target, non-social, behaviors, namely motor stereotypies or anxiety. Based on clinical data, we could have expected some reduction of stereotyped behaviors;29 however, our paradigm may not have been comprehensive and/or intensive enough to verify this. Of note, knockout mice from the OI-R group showed reduced anxiety in the novelty suppressed feeding test, likely a consequence of associating daily novel object exploration with a reward: we thus involuntarily trained these animals to display less anxiety in this particular context.
Last, behavioral intervention modified neural substrates in Oprm1−/− mice, as shown by regulated gene expression. We analyzed the expression pattern of a small collection of genes across six brain regions within the reward/social circuit and revealed that back-translating EIBI in mice was able to normalize this pattern, in correlation with behavioral markers of social abilities. As regards neuronal activity, we detected reduced C-fos mRNA level following social interaction in the reward/social circuit (NAc, CPu, MeA, and VTA/SNc), as opposed to increased expression in executive control and anxiety-related PFC and CeA, in knockout mice from the OI-R group, extending previous observations9. These results likely reflect modified connectivity within reward/aversion pathways in these animals17 and are coherent with their reduced reward sensitivity, social interest, and increased anxiety9,13. They also match imaging data in ASD patients showing decreased activity in the reward circuit in response to social stimuli7,67,68 and increased activity in the amygdala under anxiogenic social conditions69. Remarkably, SI-R training normalized C-fos expression in all these regions but the PFC. This result suggests that SI-R paradigm was able to reattribute rewarding properties to social interaction and to decrease anxiety in this context. Now regarding plasticity gene markers, we report for the first time excessive widespread Arc expression in the brain of Oprm1−/− mice following social interaction. In the CeA, MeA, and VTA/SNc, increased Arc levels were tightly correlated with a behavioral marker of social avoidance, grooming after social contact. Arc codes for activity-regulated cytoskeletal-associated protein (Arc), involved in regulating synaptic plasticity, cellular signaling, glutamate neurotransmission, and spine growth70,71. Intriguingly, levels of Arc protein were found increased in the brains of two other mouse models of ASD72,73 as well as in the blood of patients with autism74. Deficient Arc expression, however, may also be detrimental to social behavior, as shown by impaired sociability and schizophrenia-related phenotype in mice with invalidated Arc gene75 as well as genetic association between mutations in Arc and schizophrenia in humans76,77,78. Together, these data support the hypothesis of a functional connection between Arc and neurodevelopmental diseases with impaired social abilities, namely autism and schizophrenia79. Remarkably, SI-R but not SI-NR trained Oprm1−/− mice displayed normalized Arc expression in the CeA, MeA, and VTA/SNc, indicating that plastic events occurred in these regions that likely contributed to improve social abilities. Still related to plasticity, SI-R training induced or restored the expression of Bdnf in the NAc and CeA, respectively, of Oprm1−/− mice. Together, these results match data from imaging studies showing EIBI-induced brain plasticity in autistic patients80, specifically in the reward circuit for subjects who display initial hypoactivation in these regions55.
Now focusing on genes from the oxytocin/vasopressin system, behavioral training had also major effects on their expression in Oprm1−/− mice. First, we confirmed our previous observation of decreased levels of Oxt mRNA, coding for oxytocin, in the NAc of Oprm1−/− mice (OI-R group)9 and extended it to the CeA and MeA, where they were correlated with prosocial behavioral parameters. Accordingly, transcripts for the oxytocin receptor (Oxtr) were found increased in the same regions, matching binding data11. The detection of Oxt transcripts (as well as Avp mRNAs, coding for vasopressin) in brain regions outside the hypothalamus, where oxytocinergic (and vasopressinergic) neurons are localized81, might appear surprising: it implies that these mRNAs where transported to projection sites of oxytocinergic neurons. In agreement with this, Oxt mRNAs have recently been evidenced in distal projections of human stem cell-derived neurons82, suggesting that local transcription may play an important role in oxytocin (and possibly vasopressin) neurotransmission. On the vasopressin side, expression of Avpr1a, coding V1AR receptors, in mutants, was decreased in the NAc and MeA but increased in the CeA. All these data point to major alterations of the oxytocin/vasopressin system in MOR null mice that likely contributed to their autistic-like phenotype, as shown in other animal models and in patients83,84,85,86. Singularly, behavioral intervention brought oxytocin/vasopressin gene expression back to wild-type levels or even higher for Oxt and Avp in the NAc. Thus, beneficial effects of intervention on social behavior in mutants likely involved restored oxytocin/vasopressin function, a key neurobiological substrate for social reward87. Pharmacological manipulations of this system, using either oxytocin receptor agonists (including oxytocin) or V1AR receptor antagonists, can restore social abilities in animal models of ASD85, including Oprm1−/− mice11 and in patients with autism88,89. Oxytocin treatment in ASD patients increases NAc connectivity90 that was shown decreased notably as a function of OXTR risk-allele dosage:19 these data further highlight the connection between oxytocin activity and reward processing. Interestingly, our results bring additional arguments for combining pharmacological approaches targeting oxytocin with behavioral therapy91,92, by revealing shared neurobiological mechanisms.
Finally, behavioral intervention normalized (except in PFC) the expression of Crh, coding for corticotropin-releasing factor that possibly contributes to increased anxiety levels in ASD93,94, and partially restored striatal expression of Grm4, coding for the mGluR4 receptor, which activation rescues ASD symptoms in Oprm1−/− mice9. These results indicate that the neurobiological underpinnings of therapy-induced behavioral improvements spread well over plasticity markers and the oxytocin/vasopressin system, and will require further investigation.
In conclusion, we demonstrate that reattributing a rewarding value to social experience in the Oprm1−/− mouse model of ASD durably rescues deficient social abilities and modify neurobiological substrates in the reward circuitry, in accordance with the Social Motivation Theory of autism95,96. This occurred despite defective reward processing in mice lacking MOR, suggesting that palatable food pairing was able to rescue social reward in these animals, maybe by restoring oxytocin/vasopressin function. These results strongly suggest that the main key to success in EIBI programs is to restore social reward in patients with ASD. They also point to the therapeutic potential of pharmacological treatments stimulating reward processes to relieve ASD symptoms, an idea that is now emerging from clinical and imaging studies21. Such pharmacotherapy could target the oxytocin/vasopressin system as well as other key substrates for reward processing and efficiently complement EIBI programs by reducing their demand and the variability of their outcomes.
References
Le Merrer, J., Becker, J. A., Befort, K. & Kieffer, B. L. Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379–1412 (2009).
Nogueiras, R. et al. The opioid system and food intake: homeostatic and hedonic mechanisms. Obes. Facts 5, 196–207 (2012).
Panksepp, J., Herman, B., Conner, R., Bishop, P. & Scott, J. P. The biology of social attachments: opiates alleviate separation distress. Biol. Psychiatry 13, 607–618 (1978).
Smith, C. J. W., Wilkins, K. B., Li, S., Tulimieri, M. T. & Veenema, A. H. Nucleus accumbens mu opioid receptors regulate context-specific social preferences in the juvenile rat. Psychoneuroendocrinology 89, 59–68 (2017).
Burkett, J. P., Spiegel, L. L., Inoue, K., Murphy, A. Z. & Young, L. J. Activation of mu-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles. Neuropsychopharmacology 36, 2200–2210 (2011).
Loseth, G. E., Ellingsen, D. M. & Leknes, S. State-dependent mu-opioid modulation of social motivation. Front. Behav. Neurosci. 8, 430 (2014).
Pellissier, L. P., Gandia, J., Laboute, T., Becker, J. A. J. & Le Merrer, J. Mu opioid receptor, social behaviour and autism spectrum disorder: reward matters. Br. J. Pharmacol 1752750–2769 (2018).
Vanderschuren, L. J., Achterberg, E. J. & Trezza, V. The neurobiology of social play and its rewarding value in rats. Neurosci. Biobehav. Rev. 70, 86–105 (2016).
Becker, J. A. et al. Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology 39, 2049–2060 (2014).
Cinque, C. et al. Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice. Transl. Psychiatry 2, e155 (2012).
Gigliucci, V. et al. Region specific up-regulation of oxytocin receptors in the opioidoprm1 (−/−) mouse model of autism. Front. Pediatr. 2, 91 (2014).
Moles, A., Kieffer, B. L. & D’Amato, F. R. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304, 1983–1986 (2004).
Oddi, D., Crusio, W. E., D’Amato, F. R. & Pietropaolo, S. Monogenic mouse models of social dysfunction: implications for autism. Behav. Brain. Res. 251, 75–84 (2013).
Lai, M. C., Lombardo, M. V. & Baron-Cohen, S. Autism. Lancet 383, 896–910 (2014).
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn. Arlington, VA : American Psychiatric Publishing, 2013.
Argyropoulos, A., Gilby, K. L. & Hill-Yardin, E. L. Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front. Hum. Neurosci. 7, 417 (2013).
Mechling, A. E. et al. Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome. Proc. Natl Acad. Sci. USA 113, 11603–11608 (2016).
Dichter, G. S. et al. Reward circuitry function in autism spectrum disorders. Soc. Cogn. Affect. Neurosci. 7, 160–172 (2012).
Hernandez, L. M. et al. Additive effects of oxytocin receptor gene polymorphisms on reward circuitry in youth with autism. Mol. Psychiatry 22, 1134–1139 (2017).
Kohls, G., Yerys, B. E. & Schultz, R. T. Striatal development in autism: repetitive behaviors and the reward circuitry. Biol. Psychiatry 76, 358–359 (2014).
Kohls, G., Antezana, L., Mosner, M. G., Schultz, R. T. & Yerys, B. E. Altered reward system reactivity for personalized circumscribed interests in autism. Mol. Autism 9, 9 (2018).
Chevallier, C., Grezes, J., Molesworth, C., Berthoz, S. & Happe, F. Brief report: Selective social anhedonia in high functioning autism. J. Autism Dev. Disord. 42, 1504–1509 (2012).
Dawson, G. & Bernier, R. in Human behavior and the developing brain: Atypical development. 2nd edn (eds D. Coch, G. Dawson, K. Fischer) 28–55 (Guilford Press, New York, 2007).
Dove, D. et al. Medications for adolescents and young adults with autism spectrum disorders: a systematic review. Pediatrics 130, 717–726 (2012).
Ji, N. & Findling, R. L. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr. Opin. Psychiatry 28, 91–101 (2015).
Warren, Z. et al. A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics 127, e1303–e1311 (2011).
Allen-Meares, P., MacDonald, M. & McGee, K. Autism spectrum disorder updates - relevant information for early interventionists to consider. Front. Public Health 4, 236 (2016).
Reichow, B. Overview of meta-analyses on early intensive behavioral intervention for young children with autism spectrum disorders. J. Autism Dev. Disord. 42, 512–520 (2012).
Pickles, A. et al. Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial. Lancet 388, 2501–2509 (2016).
Weston, R., Hodges, A. & Davis, T. N. Differential reinforcement of other behaviors to treat challenging behaviors among children with autism: a systematic and quality review. Behav. Modif. 42, 584–609 (2017).
Matson, J. L. & Boisjoli, J. A. The token economy for children with intellectual disability and/or autism: a review. Res. Dev. Disabil. 30, 240–248 (2009).
Lovaas, O. I. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J. Consult. Clin. Psychol. 55, 3–9 (1987).
Koegel, L. K., Koegel, R. L. & Carter, C. M. Pivotal responses and the natural language teaching paradigm. Semin. Speech Lang. 19, 355–371 (1998).
Jensen, V. K. & Sinclair, L. V. Treatment of autism in young children: behavioral intervention and applied behavior analysis. Infant Young Child. 14, 42–52 (2002).
Bradshaw, J., Steiner, A. M., Gengoux, G. & Koegel, L. K. Feasibility and effectiveness of very early intervention for infants at-risk for autism spectrum disorder: a systematic review. J. Autism Dev. Disord. 45, 778–794 (2015).
Dawson, G. et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver model. Pediatrics 125, e17–e23 (2010).
Kaiser, A. P. & Hester, P. P. Generalized effects of enhanced Milieu teaching. J. Speech Hear. Res. 37, 1320–1340 (1994).
Koegel, R. L., Koegel, L. K. & McNerney, E. K. Pivotal areas in intervention for autism. J. Clin. Child Psychol. 30, 19–32 (2001).
Wetherby, A. M. et al. Parent-implemented social intervention for toddlers with autism: an RCT. Pediatrics 134, 1084–1093 (2014).
Ilg, J. et al. Evaluation of a French perent-training program in young children with autism spectrum disorder. Psychologie Française 63, 181–199 (2018).
Lei, J. & Ventola, P. Pivotal response treatment for autism spectrum disorder: current perspectives. Neuropsychiatr. Dis. Treat. 13, 1613–1626 (2017).
Johnson, K. A., Vladescu, J. C., Kodak, T. & Sidener, T. M. An assessment of differential reinforcement procedures for learners with autism spectrum disorder. J. Appl. Behav. Anal. 50, 290–303 (2017).
Leaf, J. B. et al. Changing preference from tangible to social activities through an observation procedure. J. Appl. Behav. Anal. 49, 49–57 (2016).
Smith, T., Klorman, R. & Mruzek, D. W. Predicting outcome of community-based early intensive behavioral intervention for children with autism. J. Abnorm. Child Psychol. 43, 1271–1282 (2015).
Estes, A. et al. Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder. J. Am. Acad. Child Adolesc. Psychiatry 54, 580–587 (2015).
Linstead, E. et al. An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder. Transl. Psychiatry 7, e1234 (2017).
Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819–823 (1996).
Fisher, W. et al. A comparison of two approaches for identifying reinforcers for persons with severe and profound disabilities. J. Appl. Behav. Anal. 25, 491–498 (1992).
Crawley, J. N. Mouse behavioral assays relevant to the symptoms of autism. Brain. Pathol. 17, 448–459 (2007).
Silverman, J. L., Yang, M., Lord, C. & Crawley, J. N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502 (2010).
Moustgaard, A., Hau, J. & Lind, N. M. Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats. Behav. Brain Funct. 4, 49 (2008).
Thomas, A. et al. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacol. (Berl.) 204, 361–373 (2009).
Meirsman, A. C. et al. Mice lacking GPR88 show motor deficit, improved spatial learning and low anxiety reversed by delta opioid antagonist. Biol. Psychiatry 79, 917–927 (2016).
Becker, J. A., Kieffer, B. L. & Le Merrer, J. Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol. Addict. Biol. 22, 1205–1217 (2017).
Ventola, P. et al. Heterogeneity of neural mechanisms of response to pivotal response treatment. Brain. Imaging Behav. 9, 74–88 (2015).
Yang, D. et al. Brain responses to biological motion predict treatment outcome in young children with autism. Transl. Psychiatry 6, e948 (2016).
Papaleo, F., Kieffer, B. L., Tabarin, A. & Contarino, A. Decreased motivation to eat in mu-opioid receptor-deficient mice. Eur. J. Neurosci. 25, 3398–3405 (2007).
Pecina, S. & Berridge, K. C. Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J. Neurosci. 25, 11777–11786 (2005).
Pecina, S. & Berridge, K. C. Opioid site in nucleus accumbens shell mediates eating and hedonic ‘liking’ for food: map based on microinjection Fos plumes. Brain Res. 863, 71–86 (2000).
Olmstead, M. C., Ouagazzal, A. M. & Kieffer, B. L. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS. ONE 4, e4410 (2009).
Karsten, A. M. & Carr, J. E. The effects of differential reinforcement of unprompted responding on the skill acquisition of children with autism. J. Appl. Behav. Anal. 42, 327–334 (2009).
Fisher, W. W., Pawich, T. L., Dickes, N., Paden, A. R. & Toussaint, K. Increasing the saliency of behavior-consequence relations for children with autism who exhibit persistent errors. J. Appl. Behav. Anal. 47, 738–748 (2014).
Kim, S. H., Bal, V. H. & Lord, C. Longitudinal follow-up of academic achievement in children with autism from age 2 to 18. J. Child Psychol. Psychiatry 59, 285–267 (2017).
Garbugino, L., Centofante, E. & D’Amato, F. R. Early social enrichment improves social motivation and skills in a monogenic mouse model of autism, the Oprm1 (−/−) mouse. Neural Plast. 2016, 5346161 (2016).
Pellecchia, M. et al. Child characteristics associated with outcome for children with autism in a school-based behavioral intervention. Autism 20, 321–329 (2016).
Trezza, V., Baarendse, P. J. & Vanderschuren, L. J. The pleasures of play: pharmacological insights into social reward mechanisms. Trends Pharmacol. Sci. 31, 463–469 (2010).
Kohls, G., Chevallier, C., Troiani, V. & Schultz, R. T. Social ‘wanting’ dysfunction in autism: neurobiological underpinnings and treatment implications. J. Neurodev. Disord. 4, 10 (2012).
Dichter, G. S., Damiano, C. A. & Allen, J. A. Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J. Neurodev. Disord. 4, 19 (2012).
Dalton, K. M. et al. Gaze fixation and the neural circuitry of face processing in autism. Nat. Neurosci. 8, 519–526 (2005).
Li, Y. et al. A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)‘s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression. Front. Neurosci. 9, 279 (2015).
Plath, N. et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437–444 (2006).
Kang, M. S. et al. Autism-like behavior caused by deletion of vaccinia-related kinase 3 is improved by TrkB stimulation. J. Exp. Med. 214, 2947–2966 (2017).
Cao, C. et al. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 11, e1001478 (2013).
Alhowikan, A. M. Activity-regulated cytoskeleton-associated protein dysfunction may contribute to memory disorder and earlier detection of autism spectrum disorders. Med. Princ. Pract. 25, 350–354 (2016).
Manago, F. et al. Genetic disruption of Arc/Arg3.1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia. Cell Rep. 16, 2116–2128 (2016).
Huentelman, M. J. et al. Association of SNPs in EGR3 and ARC with schizophrenia supports a biological pathway for schizophrenia risk. PLoS. ONE 10, e0135076 (2015).
Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014).
Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014).
Manago, F. & Papaleo, F. Schizophrenia: what’s Arc got to do with It? Front. Behav. Neurosci. 11, 181 (2017).
Calderoni, S. et al. Rehabilitative interventions and brain plasticity in autism spectrum disorders: focus on mri-based studies. Front. Neurosci. 10, 139 (2016).
Knobloch, H. S. & Grinevich, V. Evolution of oxytocin pathways in the brain of vertebrates. Front. Behav. Neurosci. 8, 31 (2014).
Bigler, R. L., Kamande, J. W., Dumitru, R., Niedringhaus, M. & Taylor, A. M. Messenger RNAs localized to distal projections of human stem cell derived neurons. Sci. Rep. 7, 611 (2017).
Meyer-Lindenberg, A., Domes, G., Kirsch, P. & Heinrichs, M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12, 524–538 (2011).
Johnson, Z. V. & Young, L. J. Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience. Neurosci. Biobehav. Rev. 76, 87–98 (2017).
Penagarikano, O. Oxytocin in animal models of autism spectrum disorder. Dev. Neurobiol. 77, 202–213 (2017).
Sala, M. et al. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 69, 875–882 (2011).
Kosaki, Y. & Watanabe, S. Conditioned social preference, but not place preference, produced by intranasal oxytocin in female mice. Behav. Neurosci. 130, 182–195 (2016).
Guastella, A. J. & Hickie, I. B. Oxytocin treatment, circuitry, and autism: a critical review of the literature placing oxytocin into the autism context. Biol. Psychiatry 79, 234–242 (2016).
Umbricht, D. et al. A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder. Neuropsychopharmacology 42, 1914–1923 (2017).
Gordon, I. et al. Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci. Rep. 6, 35054 (2016).
Stavropoulos, K. K. & Carver, L. J. Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention. J. Child Psychol. Psychiatry 54, 603–618 (2013).
Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J. & Reiss, A. L. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology 37, 509–518 (2012).
McGill, B. E. et al. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 103, 18267–18272 (2006).
Tsilioni, I. et al. Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. Transl. Psychiatry 4, e466 (2014).
Chevallier, C., Kohls, G., Troiani, V., Brodkin, E. S. & Schultz, R. T. The social motivation theory of autism. Trends Cogn. Sci. 16, 231–239 (2012).
Dawson, G. Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev. Psychopathol. 20, 775–803 (2008).
Acknowledgements
We thank B. Dutray (Centre Hospitalier Spécialisé de Rouffach) and B.L. Kieffer for fruitful discussions. We thank Benoit Piégu (Physiologie de la Reproduction et des Comportements) for technical advice on clustering analysis. We thank G. Duval and D. Memedov for animal care and technical assistance (Institut de Génétique et de Biologie Moléculaire et Cellulaire). We thank the Experimental Unit PAO-1297 (EU0028) from the INRA-Val de Loire Centre for animal breeding and care. This work was supported by the Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (Inserm), Université de Strasbourg, Institut National de la Recherche Agronomique (INRA), and Université de Tours. We thank the Mission for Interdiciplinarity of the CNRS for funding through the call Therapeutic Innovations for Mental Diseases. We also thank Région Centre (ARD2020 Biomédicament—GPCRAb) and LabEx MabImprove for support in this project. J.L.M. acknowledges postdoctoral fellowship from the Fondation Université de Strasbourg, generously granted by Pierre Fabre Laboratories. L.P.P. acknowledges postdoctoral support from the Marie-Curie/AgreenSkills Program.
Author information
Authors and Affiliations
Contributions
C.N.P., L.P.P., C.C., J.A.J.B., and J.L.M. designed the experiments. C.N.P., J.L.M., and J.A.J.B. performed behavioral experiments. L.P.P. and J.A.J.B. performed qRT-PCR experiments. C.N.P., L.P.P., J.A.J.B., and J.L.M. analyzed the data. C.N.P., L.P.P., C.C., J.A.J.B., and J.L.M. interpreted the results and wrote the article. All authors discussed the results and commented on the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pujol, C.N., Pellissier, L.P., Clément, C. et al. Back-translating behavioral intervention for autism spectrum disorders to mice with blunted reward restores social abilities. Transl Psychiatry 8, 197 (2018). https://doi.org/10.1038/s41398-018-0247-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-018-0247-y
This article is cited by
-
Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters
Neuropsychopharmacology (2024)
-
Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism
Neuropsychopharmacology (2022)
-
Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice
Neuropsychopharmacology (2021)
-
The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota
Microbiome (2021)